Yellowstone Program

YELLOWSTONE ProgramThe YELLOWSTONE Induction 1 and Induction 2 studies are phase 3, randomized, double-blind, placebo-controlled, multicenter trials that will investigate the efficacy and safety of an investigational oral medication being studied for individuals with moderately to severely active Crohn’s disease.

If you are interested or would like more information, please call 866-914-6994 or complete this form, and a clinical trial navigator will contact you within one business day. A clinical trial navigator will help you connect quickly with the appropriate study team and make sure you get the information you need to explore a clinical study.

 

Celgene values your privacy. The information that you provide here will only be used by Celgene, its affiliates and agents to fulfill your request to learn more about, and assess your eligibility for, Celgene clinical trials investigating whether an oral medication can improve symptoms of Crohn’s disease. Must be 18 years of age or older to sign up. Please see our Privacy Policy to learn more about Celgene’s use of your submitted personal information.